Published in J Virol on June 01, 2004
Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs. BMC Microbiol (2010) 0.85
High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection. J Invest Dermatol (2008) 0.85
Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1. J Invest Dermatol (2009) 0.85
Dominant-negative proteins in herpesviruses - from assigning gene function to intracellular immunization. Viruses (2009) 0.77
Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy. J Virol (2010) 0.75
Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections. Curr Clin Microbiol Rep (2015) 0.75
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med (1997) 7.59
Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters. J Virol (1985) 7.39
Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J (1984) 7.33
Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol (1986) 6.74
Herpes simplex virus turns off the TAP to evade host immunity. Nature (1995) 5.93
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol Cell Biol (1985) 5.76
Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation. J Virol (1985) 5.63
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell (1994) 4.70
A viral inhibitor of peptide transporters for antigen presentation. Nature (1995) 4.26
Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol (1989) 3.63
The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol (1993) 3.43
The genome sequence of herpes simplex virus type 2. J Virol (1998) 3.39
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans. J Gen Virol (1986) 3.15
Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. J Virol (1990) 3.05
An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J Virol (1995) 2.82
Sensing pathogens and tuning immune responses. Science (2001) 2.73
Herpes simplex viruses. Clin Infect Dis (1998) 2.68
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J Clin Invest (1993) 2.59
T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol (1998) 2.31
Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther (1998) 2.29
A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology (1989) 2.10
The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol (1999) 2.06
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents. J Infect Dis (1988) 1.92
Regulation of the immune response by antigen. Science (2001) 1.84
A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron (1990) 1.57
DNA sequence of the region in the genome of herpes simplex virus type 1 containing the exonuclease gene and neighbouring genes. Nucleic Acids Res (1986) 1.56
Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection. Proc Natl Acad Sci U S A (1999) 1.54
Localization dose and time of antigens determine immune reactivity. Semin Immunol (2000) 1.53
Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr Opin Immunol (2001) 1.53
Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis (2000) 1.51
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol (2000) 1.47
Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo. J Virol (2000) 1.45
Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4. J Virol (1994) 1.45
A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J Infect Dis (1997) 1.44
Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. J Virol (1994) 1.42
Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol (1996) 1.40
Mutational analysis of the sequence encoding ICP0 from herpes simplex virus type 1. Virology (1991) 1.31
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus). J Infect Dis (1990) 1.31
Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J Infect Dis (1994) 1.31
Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology (1996) 1.26
Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J Virol (1992) 1.26
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med (1995) 1.25
Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia. J Gen Virol (1991) 1.21
Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function. Vaccine (1998) 1.14
Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol (1990) 1.13
Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci U S A (1996) 1.12
Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J Virol (1994) 1.11
Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1. Virology (1997) 1.08
Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice. J Infect Dis (1997) 1.07
Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells. J Virol (2001) 1.05
Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection. J Virol (2002) 1.04
Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs. J Infect Dis (1998) 1.04
DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine (1996) 1.03
A novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant. Hum Gene Ther (1999) 0.90
MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1. Curr Eye Res (1997) 0.88
Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes. J Virol (1998) 0.87
Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein. Antiviral Res (2002) 0.86
A novel tetracycline-inducible viral replication switch. Hum Gene Ther (1999) 0.86
Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy for small-sized stage IA lung cancer. Ann Thorac Surg (2012) 2.23
Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer. Ann Thorac Surg (2012) 2.12
Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol Cell Biol (2004) 1.67
Human beta-defensin-3 promotes wound healing in infected diabetic wounds. J Gene Med (2009) 1.13
Enhanced susceptibility to infections in a diabetic wound healing model. BMC Surg (2008) 1.09
Cbl promotes clustering of endocytic adaptor proteins. Nat Struct Mol Biol (2005) 1.05
Validation of the European system for cardiac operative risk evaluation (EuroSCORE) in Chinese heart valve surgery patients. J Heart Valve Dis (2010) 1.04
Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol Rep (2009) 1.03
Autologous skin transplantation: comparison of minced skin to other techniques. J Surg Res (2002) 1.02
Impaired wound healing in an acute diabetic pig model and the effects of local hyperglycemia. Wound Repair Regen (2008) 1.01
Gene transfer strategies in tissue engineering. J Cell Mol Med (2007) 1.00
Suppressor of T-cell receptor signalling 1 and 2 differentially regulate endocytosis and signalling of receptor tyrosine kinases. FEBS Lett (2007) 1.00
CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice. EMBO J (2010) 0.96
Graft site malignancy following treatment of full-thickness burn with cultured epidermal autograft. Plast Reconstr Surg (2004) 0.96
In vivo gene delivery of Ad-VEGF121 to full-thickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing. Wound Repair Regen (2005) 0.95
Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR. J Clin Gastroenterol (2007) 0.94
Current challenges in quantitative modeling of epidermal growth factor signaling. FEBS Lett (2005) 0.94
Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector. Mol Ther (2006) 0.93
Insulin-like growth factor-1 gene therapy and cell transplantation in diabetic wounds. J Gene Med (2008) 0.92
Cultured autologous fibroblasts augment epidermal repair. Transplantation (2002) 0.89
HMGCR is necessary for the tumorigenecity of esophageal squamous cell carcinoma and is regulated by Myc. Tumour Biol (2014) 0.89
Successful treatment of patients with paraquat intoxication: three case reports and review of the literature. J Zhejiang Univ Sci B (2012) 0.87
Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression. PLoS One (2013) 0.87
Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in mice. J Virol (2011) 0.86
An ultrasensitive sorting mechanism for EGF receptor endocytosis. BMC Syst Biol (2008) 0.86
TRAF6 promoted the metastasis of esophageal squamous cell carcinoma. Tumour Biol (2013) 0.85
High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection. J Invest Dermatol (2008) 0.85
Ebstein's anomaly of the tricuspid valve with rheumatic mitral stenosis and aortic incompetence. J Heart Valve Dis (2009) 0.85
A classification method based on principal components of SELDI spectra to diagnose of lung adenocarcinoma. PLoS One (2012) 0.85
Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs. BMC Microbiol (2010) 0.85
Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1. J Invest Dermatol (2009) 0.85
PKC?-dependent activation of the ubiquitin proteasome system is responsible for high glucose-induced human breast cancer MCF-7 cell proliferation, migration and invasion. Asian Pac J Cancer Prev (2013) 0.84
Immunization with a dominant-negative recombinant HSV type 1 protects against HSV-1 skin disease in guinea pigs. J Invest Dermatol (2008) 0.84
Gene therapy in wound healing. Surg Clin North Am (2003) 0.83
Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials. PLoS One (2013) 0.83
Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma. Tumour Biol (2014) 0.82
The heterogeneous nature of polyethylenimine-DNA complex formation affects transient gene expression. Cytotechnology (2009) 0.82
Novel human BTB/POZ domain-containing zinc finger protein ZBTB1 inhibits transcriptional activities of CRE. Mol Cell Biochem (2011) 0.82
Role for ezrin in breast cancer cell chemotaxis to CCL5. Oncol Rep (2010) 0.82
Evidence for cooperative and domain-specific binding of the signal transducing adaptor molecule 2 (STAM2) to Lys63-linked diubiquitin. J Biol Chem (2012) 0.80
Hydrogen saline is protective for acute lung ischaemia/reperfusion injuries in rats. Heart Lung Circ (2012) 0.80
Gprc5a-deficiency confers susceptibility to endotoxin-induced acute lung injury via NF-κB pathway. Cell Cycle (2015) 0.80
Ability of ambulatory ECG-based T-wave alternans to modify risk assessment of cardiac events: a systematic review. BMC Cardiovasc Disord (2014) 0.79
Gene therapy in cutaneous wound healing. Front Biosci (2007) 0.79
Formulation and pharmacokinetic evaluation of tetracycline-loaded solid lipid nanoparticles for subcutaneous injection in mice. Chem Pharm Bull (Tokyo) (2011) 0.79
Cell suspension cultures of allogenic keratinocytes are efficient carriers for ex vivo gene transfer and accelerate the healing of full-thickness skin wounds by overexpression of human epidermal growth factor. Wound Repair Regen (2007) 0.78
[Activity of esterases and effect of genetic polymorphism in workers exposed to organophosphorus pesticides]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2006) 0.78
NMR reveals a different mode of binding of the Stam2 VHS domain to ubiquitin and diubiquitin. Biochemistry (2010) 0.78
EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer. Mol Cancer (2014) 0.78
Analysis on Postoperative Efficacy of Radical Hepatectomy for Patients with Non-HBV/HCV Hepatocellular Carcinoma. Asian Pac J Cancer Prev (2015) 0.77
[Comparative study of perioperative complications and lymphadenectomy between minimally invasive esophagectomy and open procedure]. Zhonghua Wei Chang Wai Ke Za Zhi (2012) 0.77
Long-term outcomes of surgical treatment for pulmonary carcinoid tumors: 20 years' experience with 131 patients. Chin Med J (Engl) (2012) 0.77
A new technique of ex vivo gene delivery of VEGF to wounds using genetically modified skin particles promotes wound angiogenesis. J Am Coll Surg (2011) 0.77
Identification and bioactivity analysis of transthyretin-like protein in amphioxus: a case demonstrating divergent evolution from an enzyme to a hormone distributor. Comp Biochem Physiol B Biochem Mol Biol (2012) 0.77
Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells. Tumour Biol (2014) 0.76
Modulation of scarring in a liquid environment in the Yorkshire pig. Wound Repair Regen (2009) 0.76
Molecular cloning, characterization and expression analysis of ubiquitin protein ligase gene (As-ubpl) from Artemia sinica. Comp Biochem Physiol B Biochem Mol Biol (2013) 0.76
Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma. Mol Carcinog (2013) 0.76
Cloning and expression analysis of the gene encoding fibrinogen-like protein A, a novel regeneration-related protein from Apostichopus japonicus. Mol Biol Rep (2014) 0.76
Gene therapy in the treatment of lower extremity wounds. Int J Low Extrem Wounds (2004) 0.76
Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma. Tumour Biol (2012) 0.76
Gene therapy in soft tissue reconstruction. Cells Tissues Organs (2002) 0.76
Differential phosphofructokinase-1 isoenzyme patterns associated with glycolytic efficiency in human breast cancer and paracancer tissues. Oncol Lett (2013) 0.76
Identification and expression of the elongator protein 2 (Ajelp2) gene, a novel regeneration-related gene from the sea cucumber Apostichopus japonicus. Mol Biol Rep (2014) 0.76
Pseudoaneurysm of the aortic arch: A rare case report of pulmonary cancer complication. Medicine (Baltimore) (2016) 0.75
Gene delivery of PDGF for wound healing therapy. J Tissue Viability (2005) 0.75
[Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction]. Zhonghua Nan Ke Xue (2004) 0.75
Expression and functional analysis of properdin in zebrafish Danio rerio. Dev Comp Immunol (2013) 0.75
Regulable Transgene Expression in Dorsal Root Ganglia of a Replication-Defective Herpes Simplex Virus Type 1 Vector by Means of Sciatic Nerve Injection. Plast Reconstr Surg (2016) 0.75
Reply to "The binding stoichiometry of CIN85 SH3 domain A and Cbl-b". Nat Struct Mol Biol (2008) 0.75
[Cloning Hap gene from non-typeable Haemophilus influenzae and expression of Hap protein in prokaryotic cell]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2009) 0.75
[Expression of survivin gene and its significance in the carcinogenesis and development of non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi (2003) 0.75
Rheological behaviors of nylon 6/silica modified melamine cyanurate non-halogen flame retardant composites. J Nanosci Nanotechnol (2013) 0.75
[Effects of oxidative stress and NF-kappaB levels in peripheral blood mononuclear cells on development of silicosis]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2011) 0.75
[Preliminary study of proteins related to blast crisis in chronic myeloid leukemia]. Zhonghua Zhong Liu Za Zhi (2009) 0.75
[Formulation optimization and drug release in vitro of membrane controlled tablets of puerarin inclusion compound]. Zhongguo Zhong Yao Za Zhi (2013) 0.75
Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer. Asian Pac J Cancer Prev (2013) 0.75
Using hyperspectral indices to measure the effect of mine dust on the growth of three typical desert plants. Guang Pu Xue Yu Guang Pu Fen Xi (2014) 0.75
[Optimized isolation and purification of non-typeable Haemophilus influenzae Haps protein]. Nan Fang Yi Ke Da Xue Xue Bao (2007) 0.75
[Application of the national diagnostic criteria of occupational mercury poisoning]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2011) 0.75
Expression and roles of As-NUPR1 protein from Artemia sinica during embryo development and in response to salinity stress. Mol Biol Rep (2014) 0.75
[Application of next generation sequencing for the analysis of patients with spontaneous abortion]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2017) 0.75
5'-Methylthioadenosine attenuates ischemia reperfusion injury after liver transplantation in rats. Inflammation (2014) 0.75
[Improved identification for trisomy 9p and partial trisomy 6q presented in a patient by array-based comparative genomic hybridization]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2016) 0.75